9,10-dimethyl-1,2-benzanthracene has been researched along with n-vinyl-2-pyrrolidinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baroni, CD; Ruco, L; Scelsi, M; Scelsi, R; Soravito, G; Uccini, S | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and n-vinyl-2-pyrrolidinone
| Article | Year |
|---|---|
T and B immunodepression during 7,12-dimethylbenz(alpha) anthracene (DMBA) carcinogenesis in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antibody Formation; Antigens; B-Lymphocytes; Benz(a)Anthracenes; Bone Marrow; Bone Marrow Cells; Cell Division; Erythrocytes; Immunosuppression Therapy; Mice; Neoplasms, Experimental; Povidone; Sheep; Spleen; T-Lymphocytes; Thymidine; Thymus Gland | 1976 |